Needle-free Delivery of COVID-19 Vaccines from PharmaJet jet injector system

Needle-free Delivery of COVID-19 Vaccines

In collaboration with other leading biotechnology companies, we are leveraging our proprietary needle-free technology and our clinical expertise for the rapid development and delivery of vaccines and therapeutics to fight the COVID-19 pandemic.

Recipient Preference

Caregiver Preference

Safe and Effective

Emergency Use Authorization of the World’s First Plasmid DNA COVID-19 Vaccine Delivered Exclusively with the PharmaJet Needle-free Injection System

In August 2021, Zydus Cadila received Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D, the world’s first plasmid DNA Vaccine for COVID-19. The vaccine, for those 12 years and above, is exclusively administered using the PharmaJet Tropis® Needle-free Injection System. Plans are moving forward to manufacture 80+ million doses of the ZyCoV-D vaccine in South Korea to be exported to several lower-middle income countries in Latin America and Asia.

COVID-19 Pre-Clinical Studies and Clinical Trials

Pre-Clinical Studies

DNA (12)
RNA (2)
Multiple (1)

Phase 1 Clinical Studies

DNA (6)

  • BioNet Asia COVIGEN
  • DIOSynVax
  • Scancell COVIDITY

RNA (1)

Phase 2 Clinical Studies

DNA (1)

  • Vaccibody VB D-01

Phase 3 Clinical Studies

DNA (1)

  • Zydus Cadila ZyCoV-D
Menu